These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10905362)

  • 1. Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population.
    Miwi H; Murai T; Sato K; Ohkura R; Yamada T; Nagahara A; Ohtaka K; Minowa T; Kurosawa A; Sato N
    J Gastroenterol; 2000; 35(7):536-9. PubMed ID: 10905362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK; Sharma BC; Ray P; Pathak CM; Singh K
    Helicobacter; 2000 Jun; 5(2):84-7. PubMed ID: 10849056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
    Adachi K; Ishihara S; Hashimoto T; Hirakawa K; Ishimura N; Niigaki M; Kaji T; Kawamura A; Sato H; Fujishiro H; Hattori S; Watanabe M; Kinoshita Y
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1187-91. PubMed ID: 11472321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
    Kashimura H; Suzuki K; Hassan M; Ikezawa K; Sawahata T; Watanabe T; Nakahara A; Mutoh H; Tanaka N
    Aliment Pharmacol Ther; 1999 Apr; 13(4):483-7. PubMed ID: 10215732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
    Cammarota G; Tursi A; Papa A; Montalto M; Veneto G; Cuoco L; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1996 Dec; 10(6):997-1000. PubMed ID: 8971300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
    Bago J; Galović A; Belosić Halle Z; Bilić A; Bevanda M; Bago P
    Wien Klin Wochenschr; 2004 Jul; 116(14):495-9. PubMed ID: 15379146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
    Kawabata H; Habu Y; Tomioka H; Kutsumi H; Kobayashi M; Oyasu K; Hayakumo T; Mizuno S; Kiyota K; Nakajima M; Kimoto K; Inokuchi H; Kawai K
    Aliment Pharmacol Ther; 2003 Jan; 17(2):259-64. PubMed ID: 12534411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
    Miki I; Aoyama N; Sakai T; Shirasaka D; Wambura CM; Maekawa S; Kuroda K; Tamura T; Kita T; Sakaeda T; Okumura K; Kasuga M
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
    Poon SK; Chang CS; Su J; Lai CH; Yang CC; Chen GH; Wang WC
    Aliment Pharmacol Ther; 2002 Feb; 16(2):291-6. PubMed ID: 11860412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
    Murakami K; Sato R; Okimoto T; Nasu M; Fujioka T; Kodama M; Kagawa J; Sato S; Abe H; Arita T
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1933-8. PubMed ID: 12390102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
    Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.